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ECEYTLY, L-dopa therapy has been used in preference to thalamotomy for treatment of Parkinson s disease. Initially, L-dopa therapy seemed to be more effective than therapy with other antiparkinsonian drugs in the management of motor symptoms, and improved the performance of most patients with parkinsonism. However, approximately 15 years' experience has shown that L-dopa causes the so-called "long-term levodopa syndrome" of hyperkinesia, an onoff or "yo-yo" phenomenon, and mental changes in which hallucinations and illusions are irreversible. So now it is considered that L-dopa therapy should be applied only in certain cases, or delayed until the patient shows marked impairment. ~' 5"7 Other available drugs for treatment of parkinsonism, such as anticholinergic agents, cytidine diphosphate choline, amantadine, bromocriptine, pergolide mesylate (8r thio)-methyl]-6-propylergonine), and lisuride hydrogen meleate (N-(D-6-methyl-8-isoergolenyl-N',N'-diethylcarbamide)), are not completely effective and have unsatisfactory clinical side effects.
We believe that ventrolateral (VL) thalamotomy is effective for improving motor symptoms in most cases. However, various treatments for chronic diseases such as parkinsonism should be evaluated by long-term follow-up studies. In this paper we present long-term postoperative data from patients followed for 10 years after unilateral or bilateral VL thalamotomy.
Clinical Material and Technique
Since 1958, the senior author (K.M.) has treated over 1400 cases of Parkinson's disease with VL thalamotomy. Initially, various surgical procedures were used in a series of about 1100 cases, but since 1964 the operative technique and method of evaluation of the operative outcome have been standardized. Using the standard procedure, VL thalamotomy was performed with a stereotaxic guide that we have devised ( Fig. 1 ) on a consecutive series of about 300 patients under local anesthesia.
In our procedure, the location of the tip of the probe is confirmed by roentgenography until the tip reaches the target point, which is the VL nucleus of the thalamus, located in pneumoencephalograms 2 to 3 m m posterior and 2 to 3 m m superior to the midpoint of the intercommissural line in the lateral view and 12 to 14 m m lateral to the midline in the anteroposterior view ( Fig. 2) . A lesion is made with a high-frequency coagulation probe, 1.8 m m in diameter with a 2-mm bare tip.* For coagulation, the temperature is maintained at 65~ for 1 to 2 minutes. This coagulation procedure is performed one to three times with the probe in slightly different positions until rigidity and tremor have diminished as judged by careful clinical observation with contralateral reinforcement techniques during surgery. ~2 The object of our standard * Coagulation probe manufactured by Tokai Rika Co., Ltd., Japan.
operative method is to obtain as much alleviation of motor symptoms as possible by maximal extension of the lesion in the target area without causing complications. Computerized tomography (CT) examination showed that the lesion was fairly large, was properly placed, and completely covered the VL nucleus in the thalamus in most cases, as reported elsewhere ~3 (Fig. 3) .
In all, 103 patients with Parkinson's disease underwent standard VL thalamotomy in the period from 1964 to 1969. Of these, 86 patients, 64 with unilateral thalamotomy (34 males and 30 females) and 22 with bilateral thalamotomy ( 17 males and five females), were followed to the end of 1981. The mean age at the time of the first operation was 51.1 years (Table 1 ) and the average time from the onset of the disease to the first operation was 4.2 years (Fig. 4) . In cases with bilateral thalamotomy, the average interval between the first and second operations was 3.1 years.
Since 1964, patients in this clinic have been evaluated according to the system of Matsumoto, et al. 9 "~j This grading system corresponds to that reported by Hoehn and Yahr in 19673 (Table 2 ). Preoperative and postoperative evaluation of the patients was made by two groups of our staff: the patients were also examined at the time of discharge, and 5 years and 10 years postoperatively. In addition, all 22 patients who received bilateral surgery were examined in their homes at the end of 1981. Their activities and present status were None of the 86 patients received L-dopa therapy preoperatively. However, after unilateral surgery, 31 of the 64 patients received medication with L-dopa for an average of 3.9 _+ 2.7 years, and after bilateral surgery eight of the 22 patients received L-dopa for an average of 1.5 ___ 0.7 years. In three of the 22 cases with bilateral surgery, medication with L-dopa was discontinued because of marked improvement of symptoms.
S u m m a r y of Cases

Immediate Outcome
The surgical outcome at the time of discharge is shown in Table 3 for the 103 cases as a verification of our operative standard in the period from 1964 to 1969. There were no deaths, but transient confusion was observed in about 10% and transient hemifacial weakness was seen in about 8% of the patients during their hospitalization. In the follow-up study, two cases in Grade I, two in Grade IIa, seven in Grade lib, and six in Grade III were lost to follow-up review. Table 4 . For definition of grading see Table 2 .
Outcome 10 Years Postoperatively
Unilateral Surgery. Of the 64 patients who underwent unilateral surgery, six were graded preoperatively as Grade I, 20 as Grade IIa, 23 as Grade lib, and 15 as Grade III (Fig. 5) . Ten years later, there was no noticeable progression of the disease in three patients (50%) in Grade I, nine (45%) in Grade IIa, 13 (56.5%) in Grade lib, and six (40%) in Grade III. Thus, 31 of 64 patients (48.4%) maintained the same grade they exhibited at the time of their discharge without progression of the disease. Moreover, an improved condition was noted in five patients (25%) in Grade IIa, six (26%) in Grade lib, and three (20%) in Grade III.
Death resulted in 19 patients in the unilateral surgery group and in two in the bilateral surgery group, but was considered to be caused by progression of Parkinson's disease in only eight cases (Table 4) . However, a rela- 86 17 * Grade of surgical outcome: G = satisfactory results with complete alleviation of tremor and rigidity. FT = no rigidity remained. Tremor remained, but was reduced. FR = no tremor noted. Rigidity remained, but was reduced. FTR = neither tremor nor rigidity were alleviated completely. FB = bradykinesia persisted. P = improvement of motor symptoms estimated clinically as less than 50%. tionship between L-dopa medication and suicide could not be excluded in three cases. Relationships between preoperative condition and postoperative course are shown in Fig. 6 . The patients were divided into four groups according to age at the time of operation: less than 40 years old, 40 to 49 years, 50 to 59 years, and 60 years or more (Fig. 6A) . The older patients tended to show more rapid progression of the disease, judging from the mean grading scores. There was no apparent difference in progression of the disease in males and females in the 10-year period after surgery (Fig. 6B) .
The series was divided into four groups on the basis of the duration of preoperative history: 2 years or less, 3 to 5 years, 6 to 10 years, and 11 years or more. The group with a preoperative history of 11 years or more showed an apparently benign course after surgery (Fig. 6C ). Patients were also divided into four groups according to their preoperative grading: I, IIa, lib, and III (Fig. 6D ). Grade I patients had the shortest average history of Parkinson's disease. Immediate postoperative results are discussed above. During the follow-up period, most patients deteriorated one grade, and 10 years after surgery the mean grading of each group had increased.
Preoperative cardinal symptoms (Table 5) were assessed in 16 patients in Grade IIa and 20 in Grade lib, for a total of 36 patients. The cases were divided into four groups according to their predominant symptoms: tremor, rigidity, both together, and bradykinesia. A 10-year follow-up study of these patients showed no progression of tremor in five of seven Grade IIa patients or in all three patients in Grade lib. No progression of rigidity was seen in three of eight cases in Grade IIa and in eight of 15 in Grade lib. Therefore, Grade IIa and lib patients with tremor seemed to have a rather more benign course than did patients with rigidity.
In all, 31 patients with unilateral procedures received L-dopa after surgery, and 33 patients did not (Fig. 7) . Table 2 . PD = Parkinson's disease; R = rigidity; B = bradykinesia; T = tremor.
No progression was seen in 12 patients (38.7%) in the former group or in 19 patients (57.6%) in the latter. Thus, there was no value in L-dopa therapy in about half the cases and about half of them maintained a "good surgical condition" for at least 10 years postoperatively. Detailed case analyses are given elsewhere. 11,|3
There was no difference in progression of the disease in cases with left or right thalamotomy.
Bilateral Surgery. Before the first operation, the 22 cases were graded as follows: one in Grade I, eight in Grade Ila, nine in Grade lib, and four in Grade III (Fig.  8 ). Indications for a second surgical intervention included: 1) good results with complete disappearance of rigidity and tremor after the first operation, without any complication; 2) immediate postoperative improvement persisting for more than 12 months after surgery; 3) progression of motor symptoms to the nonoperated side; 4) as long an interval as possible between the first and second operations; 5) the patient's age of less than 70 years; and 6) absence of vegetative signs or other contraindications for surgery.
In the 22 cases, the interval between operations ranged from 1 to 7 years (average 3.1 years). Before the second surgery, the cases were classified as three in K. Matsumoto, F. Shichijo and T. Fukami * T = tremor predominant; R = rigidity predominant; B = bradykinesia predominant. For definition of grading see Table 2 .
Grade I, 11 in Grade IIa, and eight in Grade IIb. There was no case in Grade III because all the patients showed marked unilateral alleviation of motor symptoms. Ten years after the second intervention (Table 6 ), 14 patients (63.6%) showed no apparent progression of the disease, 13 (59.1%) had been in better condition for nearly 15 years from the time of the first operation, and two had died of cancer (Table 4) . Two patients had shown complete disappearance of tremor and rigidity and had maintained full social activities without medication for over 10 years, two patients showed minor unilateral motor symptoms but still maintained full social activities without medication, and three maintained activities with medication. Details of the cases are summarized in Table 6 .
Illustrative Case Reports
Case 1
This 59-year-old woman had developed tremor and rigidity of the left hand at 40 years old. This progressed to both left limbs, and, about 2 years before admission to the hospital, tremor and rigidity were noticed in the right limbs. At this time the patient also became bradykinetic. On admission at 46 years old, the patient showed marked rigidity and constant tremor of her left limbs, moderate rigidity, occasional tremor of her right limbs, and moderate bradykinesia. She was under medication with Artane (trihexyphenidyl, 2 rag/8 hrs) and Akineton (biperiden, 2 mg/8 hrs). Her parkinsonism was evaluated as Grade IIb preoperatively. Left VL thalamotomy was performed, but at the time of discharge she still showed occasional tremor of her right hand, although there was no rigidity of her right limbs. Medications were continued at the same doses as preoperatively. Six months after surgery, her right hand tremor had decreased markedly, and after 1 year it had disappeared completely. Her parkinsonism was evaluated as Grade IIa at that time.
Later, her left-sided tremor and rigidity also im- Table 4 ). For definition of grading see Table 2 .
proved without any additional medication. Three years after surgery, medication was reduced to Akineton (2 mg/8 hrs) only. At present, 12 years after surgery, she has occasional tremor of the left hand, but has little trouble with daily activities as a housewife. Her condition is now evaluated as Grade I.
Case 2
This 66-year-old man had suffered from Parkinson's disease, starting with occasional tremor and moderate rigidity of his left limbs, for about 10 years before his present hospital admission. On admission at 54 years old, he showed moderate rigidity and nearly constant tremor of his left limbs, with very occasional tremor of his fight hand. There was no noticeable rigidity or tremor of his fight leg, No bradykinesia was noted. Preoperatively the patient was evaluated as Grade I and was given Artane (2 mg/8hrs). After fight VL thalamotomy, he recovered and the tremor and rigidity of his left limbs disappeared completely. He discontinued his own medication postoperatively, and returned to full social activities without difficulty. However, 4 years after surgery, occasional tremor of his fight hand reappeared, and a left VL thalamotomy was recommended. The patient did not agree, because resumption of medication with Artane (2 mg/8 hrs) caused some alleviation of the tremor in his fight hand. Motor symptoms on the right side progressed slowly. At present, he is taking Artane (2 mg/8 hrs) and Akineton (2 mg/8 hrs). There is no rigidity or tremor on his left side, but he has moderate rigidity of his fight limbs and constant tremor of his fight hand. Now, 12 years after surgery, we are still recommending a second intervention,
Case 3
This 67-year-old man developed Parkinson's disease at the age of 52 years, with tremor of the left leg. On admission to the hospital, he was 56 years old and showed marked rigidity of the left limbs and moderate rigidity of the right limbs. Tremor was noted in both hands and tremor of the left leg was most marked and severe. Daily activities were somewhat disturbed at this time. His condition was evaluated as Grade lib preoperatively. Immediately after the right VL thalamotomy, he showed hyperactivity of tendon reflexes with complete disappearance of rigidity on the left side. However, occasional tremor of his left leg persisted. One year after surgery he became bradykinetic, and was given L-dopa (1.2 gm/day), Artane (2 mg/8 hrs), and Akineton (2 mg/12 hrs), After this, he became very active without rigidity or tremor of either side for about 5 years, However, in the next 3 years, occasional tremor and mild rigidity reappeared on both sides. Since his postoperative course suggested possible capsular involvement in the previous fight-sided thalamotomy, and the improvement in his left limbs was not maintained after surgery, we decided against a second intervention.
At present, 10 years after surgery, his condition is classified as Grade IIa, and he is receiving L-dopa (l.2 gm/day), Artane (2 mg/8 hrs), and Trimor (pirobeptine HCI, 2 mg/8 hrs).
Case 4
This 59-year-old woman developed Parkinson's disease, with rigidity of the fight side and tremor, at the age of 43 years. After 1 year, the rigidity and tremor spread to the left limbs as well, and she became bradykinetic. On her first admission to the hospital, she showed marked tremor and rigidity of the fight limbs and moderate rigidity and occasional tremor of the left hand. Her condition was evaluated as Grade IIb preoperatively. She was receiving Akineton (2 rag/8 hrs) and Cogentin (benztropine, 2 mg/12 hrs).
After left VL thalamotomy, motor symptoms of the fight side completely disappeared, and her condition was classified as Grade IIa. However, 1 year later, the symptoms of the left side progressed, and so she underwent right VL thalamotomy. She recovered well from the second surgery with complete alleviation of the rigidity and tremor of her left limbs. However, she had some difficulty in speech, showing so-called "word blocking" postoperatively. This condition lasted for about 5 years with slow improvement. During convalescence from the second surgery, she also showed some slowness in daily locomotive activity. When given L-dopa (1.0 gm/day) in addition to anticholinergic medication, she became apparently more active. However, she reduced the dose of L-dopa herself, because of nausea and an unpleasant sensation after taking this drug, and finally she discontinued L-dopa medication completely 5 years after the second intervention, even though her slow ambulation had not changed. She then stopped taking anticholinergic agents as well. At present, 13 years after the second intervention, she is not taking any medication for Parkinson's disease and is living a normal life, except that her voice is low and she has a little difficulty in speech. Table 2 ). Abbreviations: T = tremor; R = rigidity; B = bradykinesia; --= none; _+ = trace; + = slight; ++ = moderate; +++ = marked; speech disturbance: word blocking; anticho. = anticholinergic agent; amant. = amantadine; nor = nearly normal motor activity; ADL = activity of daily living (1: self-sufficient; 2: semi-self-sufficient; 3: able to walk; 4: confined to bed). et aL (see Table 2 ). Abbreviations: T = tremor; R = rigidity; B = bradykinesia; --= none; ___ = trace; + = slight; ++ = moderate; +++ = marked; speech disturbance: word blocking; anticho. = anticholinergic agent; amant. = amantadine; nor = nearly normal motor activity; ADL = activity of daily living (1: self-sufficient; 2: semi-self-sufficient; 3: able to walk; 4: confined to bed).
Long-term results of thalamotomy for parkinsonism
Discussion
In patients with Parkinson's disease, rigidity and tremor of the limbs and bradykinesia are the symptoms most disabling in daily activities. Progression of these motor symptoms and symptoms of the autonomic nervous system leads to a serious condition or death.
There are many reports on the therapeutic effects of various treatments on individual motor symptoms over very limited observation periods. However, an important point in the treatment of parkinsonism is to prevent progression of the disease over a long period. Accordingly, we evaluated the surgical outcome of thalamotomy from this standpoint, chiefly on the basis of the locomotive and daily activities of the patients. Thus, this paper does not give details of postoperative followup studies on rigidity and tremor. However, we would like to point out that in cases showing minor residual tremor with complete disappearance of rigidity at the time of discharge, the residual tremor may decrease without any special medication within a year after the operation. This was observed in eight of 16 cases in the present series (Ix , Table 3 ).
Markham, et al., 6 presented a very handy graphic method for evaluation of various treatments related to morbidity, progression, and mortality in primary Parkinson's disease. As a guide to therapy, they recorded numbers of patients who died or were in Hoehn and Yahr's Grade 4 or 5 (severely disabled) in relation to the duration of the treatment.
Recently, Kelly and Gillingham 4 reported long-term results of unilateral stereotaxic surgery in 60 patients with Parkinson's disease. They made precise observations on the postoperative course of rigidity and tremor as well as on the effect of L-dopa therapy. In a 10-year study of 34 surgical cases and 36 cases receiving L-dopa therapy, they observed that only 10 patients remained in Class I (no significant difficulty resulting from symptoms of the disease), 10 died, and 24 were in various stages of dependency in spite of contralateral surgical procedures. Figure 9 shows the progression curves for severe disability or death obtained from the data of Hoehn and Yahr 3 on the natural history of primary Parkinson's disease, from the results obtained by Sweet and McDowel117 and Markham, et al., 6 with L-dopa therapy, and from the findings of Kelly and Gillingham 4 and our data on the outcome of surgical therapy. Our patients who received only unilateral surgery showed a rather poorer course than did those of Kelly and Gillingham, although the course of our patients after bilateral surgery seemed better than those reported by Kelly and Gillingham. 4 However, in both series, surgical treatment seemed to be better than medication, because the ratios of disabled and dead to the total number in each group depicted in Fig. 9 were lowest in the two surgical series. Stellar, et al., 16 pointed out that L-dopa-induced hyperkinesia does not appear in limbs on the operated K. Matsumoto, F. Shichijo and T. Fukami side. Matsumoto, et al., 9 also reported a case showing complete disappearance of L-dopa-induced hyperkinesia and the on-off phenomenon after bilateral surgery. This patient was able to reduce the dose of L-dopa and finally discontinue L-dopa therapy at a time when he was enjoying completely self-sufficient daily life.
In the past, the value of bilateral thalamotomy as a treatment of parkinsonism has been controversial, because motor symptoms frequently reappear in limbs that have previously been alleviated and severe mental deterioration and speech disturbance with word blocking developed after the second intervention. However, our previous 9 and present findings show that this is not true. Our recent experience has indicated that this speech complication is minor because it does not disturb the daily life of the patients and can be improved slowly by speech therapy. Moreover, this complication was observed in only six of 30 recent cases after bilateral surgery. If indications for a second operation are strictly considered, a second surgical intervention is satisfactory with long-lasting results in most cases.
Our criteria for a second intervention are based on our clinical experience, which indicates that, if the lesion involves the capsular area with clinical manifestation of limb weakness, the alleviated motor symptoms will return with rigidity and spasticity within 1 year. In this series, several patients with unilateral surgery presented this condition, and showed definite progression of the disease in a long-term observation period. Therefore, we think that capsular involvement should be avoided in making the lesion. We conclude from our Long-term results ofthalamotomy for parkinsonism series that surgical treatment with a fairly large and properly placed thalamic lesion covering the VL nucleus completely prevents the complication of L-dopainduced hyperkinesia, and that such lesions may have a preventive effect on progression of the disease in some cases.
Cooper 2 had the same impression that successful unilateral thalamotomy reduced the incidence of subsequent development of tremor and rigidity on the contralateral side and seemed to affect the rate of progression of the disease. However, these possibilities could not be proven by Scott, et aL, 15 in reviewing their own cases of successful and unsuccessful thalamotomy over a 5-year period. In our series, evaluation 10 years after surgery indicated definite progression of the disease in cases of unilateral thalamotomy, as shown in Fig. 6 .
Our results included a number of interesting cases, with 31 of 64 cases showing practically no progression or improvement (Fig. 5) . It is well known that some cases of primary Parkinson's disease show very slow progression. These may be considered cases of "benign parkinsonism" and may constitute about 10% of all cases. However, 48.4% of our unilateral surgery cases showed practically no progression and some even exhibited improvement in the 10-year period. Although no control study was done, this finding should be evaluated and considered. It seems hard to believe that unilateral thalamotomy has an effect in reducing progression, but many neurosurgeons, including us, have observed that unilateral thalamotomy produced definite improvement of rigidity and tremor of the limbs on the operated side as well as some improvement of motor signs in the limbs on the other side in certain cases.
Matsumoto, eta/., 10'14 reported that intraoperative unilateral stimulation of the VL nucleus evoked bilateral cortical responses in man. These observations may be related to some mechanism inhibiting progression of motor symptoms after unilateral thalamotomy. Another factor that should be considered is that the incidence of Parkinson's disease is lower in Japanese (36.7 to 65.4 per 100,000) than in Caucasians (120 to 160 per 100,000). 8,18 Does this mean that the percentage of benign cases of parkinsonism is higher in Japanese? We have no answer to this question.
In our series, none of the patients undergoing unilateral surgery had received L-dopa therapy preoperatively, and of the patients with bilateral surgery, none had received L-dopa before the second intervention. This fact is noteworthy because in our experience the results of unilateral thalamotomy are not so satisfactory in patients who have received L-dopa therapy for a long period preoperatively. We think that the presence of a fairly large lesion covering the whole area of the VL nucleus without capsular involvement, and no L-dopa therapy before the first intervention, are the two major factors for obtaining a successful outcome with no progression of the disease postoperatively. Our series of patients who underwent bilateral surgery cannot be classified as having "benign parkinsonism," because they all showed definite progression before the second intervention. Most of the cases showed cessation of the disease for some period, and some of them had an unbelievably benign postoperative course for over I0 years after bilateral surgery.
Finally, it should be pointed out that we are now in an era of computer imaging. Lesions made at thalamotomy can easily be identified by CT scanning. In the future, the operative outcome of thalamotomy should be considered in relation to the three-dimensional location of lesions determined by CT scanning.
